Gennady Smagin has a strong background in pharmacology and clinical development, with experience in various reputable companies such as MindMed, Melior Discovery, and PsychoGenics. Their career spans over two decades, including roles as Director, Principal Scientist, and Faculty member. Gennady holds an MD from Siberian State Medical University, a Ph.D. from Scientific and Research Institute of Experimental Medicine, and completed postdoctoral studies in Behavioral Neurochemistry and Neuropharmacology at Louisiana State University School of Medicine in Shreveport.
September, 2023 - present
September, 2021